Skip to content
← Back to markets
Market profile · IN

India

The world's most populous market, a pharmaceutical power, and one of the most complex customs regimes

India is at once an enormous market, the source of generics and active ingredients for the whole Union, and a country where tariffs and paperwork can stop a project. Negotiations on a free-trade agreement with the Union ended on 27 January 2026 and on 11 September 2026 the Commission proposed that the Council sign and conclude it. It is not yet in force. Anyone going in needs a local partner — not because a rule says so, but because distribution cannot be run without one.

pharmatextilesIT services
Market figures

Loading the indicators…

News from the country

Recent trade news from this country's authorities and newsrooms — tariffs, taxes, sanctions, currency, imports and exports. Headlines are in the original language; the article opens at the publisher. We add no comment.

Loading news…

Interested in this market?

Write to us. Our representative for this market or our team receives it.

Something missing?

Tell us what you came to this page for and did not find. We will add it — with a source.

Write to us
Embassies and consulates

A visa, legalising a document, an invitation letter, the commercial attaché before a trade fair — these only go through a mission. Below are the official registers rather than transcribed addresses: missions move and consular hours change several times a year, so a link to the register stays current where a transcript would not.

Where a country has no mission in Bratislava or Prague it is usually accredited from Vienna, Berlin or Warsaw — the register says which.

Every figure names the authority that published it and the date the line was last worked on. This is not legal or tax advice — verify a figure with the named source before you act on it.

Other markets